From AI Pilots To Patient Impact: Scaling Safely With Local AI

With predictable costs and on-site data control, healthcare leaders no longer have to choose between innovation and compliance.

Across health systems, the debate over artificial intelligence has quietly moved on. The question is no longer “should we adopt AI.” It’s “how do we scale agentic AI safely and sustainably.” For many healthcare workflows, that means deciding which AI workloads should run close to sensitive data and expert users, and which should scale through shared enterprise or cloud environments. Agentic AI, meaning systems that can reason across tasks, orchestrate tools, and support next-step actions with appropriate human oversight, holds real promise for diagnostics, documentation, and operations. But moving from pilot to production is where many organizations stall.

The reasons are consistent. According to the Dell Modern Enterprise Readiness Study (June 2026)¹, which surveyed 376 healthcare and life sciences leaders, almost two thirds (62%) have security or compliance concerns with employees using unapproved AI tools on company devices. At the same time, more than half (53%) rank establishing and scaling AI capabilities as a top priority for the next 24 months. That tension between ambition and reality defines the current moment.

Two barriers surface again and again: unclear cost and return on investment and worries over data privacy and HIPAA compliance. Both can be addressed with the right workload placement, governance model, and infrastructure strategy. Here’s what the data and the most recent published research show, and what leaders can do about it.

The Real Barrier Isn’t Adoption, It’s Scale

Most health systems have already run an AI pilot of some kind. The harder work is turning those experiments into secure, organization-wide deployments that hold up under clinical and financial scrutiny.